We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
701
People Inc
PPLI
$3.1B
| $12.8M | 0.02% |
+587,837
| New | +$13.2M |
|
702
Zoetis
ZTS
$31.6B
| $12.8M | 0.02% |
177,832
+4,186
| +2% | +$288K |
|
703
Arthur J. Gallagher & Co
AJG
$63.7B
| $12.7M | 0.02% |
201,203
-13,253
| -6% | -$847K |
|
|
AGR
704
DELISTED
Avangrid, Inc.
AGR
| $12.6M | 0.02% |
250,045
-730,705
| -75% | -$37M |
|
|
ATH
705
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $12.6M | 0.02% |
244,428
+4,318
| +2% | +$221K |
|
|
AERI
706
DELISTED
Aerie Pharmaceuticals
AERI
| $12.6M | 0.02% |
210,859
+41,369
| +24% | +$2.51M |
|
|
ALXN
707
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.6M | 0.02% |
105,244
+20,098
| +24% | +$2.45M |
|
708
Highwoods Properties
HIW
$3.71B
| $12.6M | 0.02% |
246,686
+559
| +0.2% | +$28.8K |
|
709
IBM
IBM
$202B
| $12.5M | 0.02% |
85,258
-231,921
| -73% | -$33.7M |
|
|
VNTR
710
DELISTED
Venator Materials PLC
VNTR
| $12.5M | 0.02% |
565,100
+292,700
| +107% | +$6.72M |
|
|
CLGX
711
DELISTED
Corelogic, Inc.
CLGX
| $12.4M | 0.02% |
269,070
+772
| +0.3% | +$35.7K |
|
|
WAIR
712
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $12.4M | 0.01% |
1,669,739
-26,076
| -2% | -$216K |
|
|
CONE
713
DELISTED
CyrusOne Inc Common Stock
CONE
| $12.4M | 0.01% |
207,498
+3,920
| +2% | +$238K |
|
714
Roku
ROKU
$21.1B
| $12.3M | 0.01% |
237,910
-162,090
| -41% | -$5.58M |
|
|
WOW
715
DELISTED
WideOpenWest
WOW
| $12M | 0.01% |
1,135,553
+42,401
| +4% | +$498K |
|
716
Ascendis Pharma A/S
ASND
$16.7B
| $11.9M | 0.01% |
297,140
-220
| -0.1% | -$8K |
|
717
Helmerich & Payne
HP
$3.53B
| $11.7M | 0.01% |
180,718
-114,328
| -39% | -$6.41M |
|
|
ORIT
718
DELISTED
Oritani Financial Corp. New
ORIT
| $11.6M | 0.01% |
710,215
-60,325
| -8% | -$1.01M |
|
719
Customers Bancorp
CUBI
$2.59B
| $11.4M | 0.01% |
439,171
-1,147
| -0.3% | -$32.6K |
|
|
ORBK
720
DELISTED
Orbotech Ltd
ORBK
| $11.4M | 0.01% |
226,572
-101,847
| -31% | -$4.96M |
|
|
TVTY
721
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $11.3M | 0.01% |
308,502
-20,825
| -6% | -$790K |
|
|
ONCE
722
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $11.2M | 0.01% |
+218,769
| New | +$15.7M |
|
723
Equity Lifestyle Properties
ELS
$12.8B
| $11.1M | 0.01% |
248,804
-12,676
| -5% | -$564K |
|
724
Community Health Systems
CYH
$385M
| $11M | 0.01% |
2,589,076
+985,601
| +61% | +$4.95M |
|
|
PPL
725
PPL Corp
PPL
$27.3B
| $10.8M | 0.01% |
349,888
+322,924
| +1,198% | +$11.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.